tefinostat (CHR-2845) / Chroma Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tefinostat (CHR-2845) / Chroma Therap
2015-002281-23: A clinical trial to test the safety and effectiveness of a new drug, tefinostat, for patients with chronic myelomonocytic leukaemia

Ongoing
2
40
Europe
Tefinostat, CHR-2845, Capsule
Cardiff University
Chronic myelomonocytic leukaemia (CMML), CMML is a form of leukaemia characterised by high numbers of white blood cells called monocytes in the blood and bone marrow., Diseases [C] - Cancer [C04]
 
 
CHR-2845, NCT02759601 / 2012-000326-22: Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)

Unknown status
1/2
69
Europe
Tefinostat
Queen Mary University of London, Chroma Therapeutics
Hepatocellular Carcinoma
12/18
12/18

Download Options